PLATINUM INVESTMENT MANAGEMENT LTD - Q2 2017 holdings

$3.68 Billion is the total value of PLATINUM INVESTMENT MANAGEMENT LTD's 73 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 0.0% .

 Value Shares↓ Weighting
SLB  SCHLUMBERGER LTD$65,227,000
-15.7%
990,7000.0%1.77%
-17.4%
LVLT  LEVEL 3 COMMUNICATIONS INC$17,108,000
+3.6%
288,5000.0%0.46%
+1.8%
GOLD  BARRICK GOLD CORP$9,332,000
-16.2%
586,5950.0%0.25%
-18.1%
INFN  INFINERA CORPORATION$3,518,000
+4.3%
329,8000.0%0.10%
+3.2%
NEM  NEWMONT MINING CORP$3,271,000
-1.7%
101,0000.0%0.09%
-3.3%
ICLR  ICON PLC$2,298,000
+22.7%
23,5000.0%0.06%
+19.2%
AERI  AERIE PHARMACEUTICALS INC$2,233,000
+15.9%
42,5000.0%0.06%
+15.1%
LIVN  LIVANOVA PLC$2,067,000
+24.9%
33,7820.0%0.06%
+21.7%
IRWD  IRONWOOD PHARMACEUTICALS INC$1,972,000
+10.7%
104,5000.0%0.05%
+10.2%
AGIO  AGIOS PHARMACEUTICALS INC$1,841,000
-11.9%
35,8000.0%0.05%
-13.8%
INCY  INCYTE CORP$1,695,000
-5.8%
13,4640.0%0.05%
-8.0%
SGEN  SEATTLE GENETICS INC$1,655,000
-17.7%
32,0000.0%0.04%
-19.6%
MRUS  MERUS N V$1,620,000
-35.0%
102,2190.0%0.04%
-36.2%
PFE  PFIZER INC$1,599,000
-1.8%
47,6100.0%0.04%
-4.4%
GRPN  GROUPON INC$1,562,000
-2.3%
407,0000.0%0.04%
-4.5%
NSTG  NANOSTRING TECHNOLOGIES INC$1,521,000
-16.8%
92,0000.0%0.04%
-19.6%
INFI  INFINITY PHARMACEUTICALS INC$1,272,000
-51.4%
810,2320.0%0.04%
-52.1%
BMRN  BIOMARIN PHARMACEUTICAL INC$1,255,000
+3.5%
13,8200.0%0.03%0.0%
MRK  MERCK & CO INC$1,204,000
+0.8%
18,8000.0%0.03%0.0%
NXPI  NXP SEMICONDUCTORS N V$1,039,000
+5.7%
9,5000.0%0.03%
+3.7%
UTX  UNITED TECHNOLOGIES CORP$976,000
+8.8%
8,0000.0%0.03%
+8.0%
ACAD  ACADIA PHARMACEUTICALS INC$900,000
-18.9%
32,3000.0%0.02%
-22.6%
TWX  TIME WARNER INC$745,000
+2.8%
7,4210.0%0.02%0.0%
XLNX  XILINX INC$720,000
+11.1%
11,2000.0%0.02%
+11.1%
VRSN  VERISIGN INC$520,000
+6.8%
5,6000.0%0.01%
+7.7%
FB  FACEBOOK INCcl a$292,000
+6.2%
1,9400.0%0.01%0.0%
AMFW  AMEC FOSTER WHEELER PLCsponsored adr$180,000
-8.6%
29,9080.0%0.01%0.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
INTEL CORP42Q3 20238.3%
MICRON TECHNOLOGY INC42Q3 20239.1%
CISCO SYS INC42Q3 20236.9%
EBAY INC.39Q1 20235.9%
INFINITY PHARMACEUTICALS INC39Q4 20220.1%
SKYWORKS SOLUTIONS INC38Q3 20236.0%
ORACLE CORP38Q3 20237.8%
BARRICK GOLD CORPORATION37Q2 20225.4%
JD.COM INC36Q3 20232.8%
MICROSOFT CORP35Q3 20238.9%

View PLATINUM INVESTMENT MANAGEMENT LTD's complete holdings history.

Latest significant ownerships (13-D/G)

View PLATINUM INVESTMENT MANAGEMENT LTD's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-13
13F-HR2024-02-13
SC 13G2024-02-12
SC 13G2024-02-12
SC 13G2024-02-12
13F-HR2023-11-03
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
SC 13G2023-02-09

View PLATINUM INVESTMENT MANAGEMENT LTD's complete filings history.

Compare quarters

Export PLATINUM INVESTMENT MANAGEMENT LTD's holdings